Maria Karina

466 total citations
12 papers, 291 citations indexed

About

Maria Karina is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Maria Karina has authored 12 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Maria Karina's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (2 papers). Maria Karina is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (2 papers). Maria Karina collaborates with scholars based in Greece and Germany. Maria Karina's co-authors include George Fountzilas, Evangelia Razis, Dimosthenis Skarlos, D. Tsavdaridis, Christos Christodoulou, Helen Gogas, Stefanos Labropoulos, V. Georgoulias, Pavlos Papakostas and Dimitriοs Mavroudis and has published in prestigious journals such as BMC Cancer, Acta Oncologica and Anti-Cancer Drugs.

In The Last Decade

Maria Karina

12 papers receiving 277 citations

Peers

Maria Karina
Wangjuh Chen United States
Trevor Feinstein United States
Raven Quinn United States
S.-B. Kim South Korea
Maria Karina
Citations per year, relative to Maria Karina Maria Karina (= 1×) peers Ferdinand Haslbauer

Countries citing papers authored by Maria Karina

Since Specialization
Citations

This map shows the geographic impact of Maria Karina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Karina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Karina more than expected).

Fields of papers citing papers by Maria Karina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Karina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Karina. The network helps show where Maria Karina may publish in the future.

Co-authorship network of co-authors of Maria Karina

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Karina. A scholar is included among the top collaborators of Maria Karina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Karina. Maria Karina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Briasoulis, Evangelos, Vassilis Golfinopoulos, Maria Karina, et al.. (2010). Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study. Anti-Cancer Drugs. 21(8). 785–789. 4 indexed citations
2.
Kostopoulos, Ioannis, Vasilios Karavasilis, Maria Karina, et al.. (2009). Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy. BMC Cancer. 9(1). 339–339. 35 indexed citations
3.
Pentheroudakis, George, Evangelos Briasoulis, Haralabos P. Kalofonos, et al.. (2008). Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: A multicentre Hellenic Cooperative Oncology Group phase II study. Acta Oncologica. 47(6). 1148–1155. 28 indexed citations
4.
Timotheadou, Eleni, D. Skarlos, E. Samantas, et al.. (2008). Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.. PubMed. 27(6C). 4481–9. 17 indexed citations
5.
Skarlos, Dimosthenis, Maria Bai, Anna Goussia, et al.. (2007). Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group.. PubMed. 27(4C). 2973–83. 13 indexed citations
6.
Fountzilas, George, Anna Kalogera‐Fountzila, Maria Karina, et al.. (2007). Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation.. PubMed. 26(6C). 4675–86. 20 indexed citations
7.
Razis, Evangelia, et al.. (2006). Three Case Reports of Hand-Foot Syndrome with Gefitinib. Cancer Investigation. 24(5). 514–516. 11 indexed citations
9.
Karanikiotis, Charisios, et al.. (2005). A novel chromatographic method for Ep-CAM mRNA detection in peripheral blood and bone marrow of patients with metastatic colorectal cancer.. PubMed. 25(1A). 319–23. 3 indexed citations
10.
Pectasides, Dimitrios, Gerasimos Aravantinos, George Fountzilas, et al.. (2005). Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.. PubMed. 25(5). 3553–8. 44 indexed citations
11.
Fountzilas, George, Christos Christodoulou, D. Tsavdaridis, et al.. (2004). Paclitaxel and Gemcitabine, As First-Line Chemotherapy, Combined with Trastuzumab in Patients with Advanced Breast Cancer: A Phase II Study Conducted by the Hellenic Cooperative Oncology Group (HeCOG). Cancer Investigation. 22(5). 655–662. 21 indexed citations
12.
Fountzilas, George, Evangelia Razis, D. Tsavdaridis, et al.. (2003). Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group. Clinical Breast Cancer. 4(2). 120–125. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026